| 000 | 01288 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518053712.0 | ||
| 264 | 0 | _c20190918 | |
| 008 | 201909s 0 0 fre d | ||
| 022 | _a1769-6917 | ||
| 024 | 7 |
_a10.1016/j.bulcan.2019.07.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLouvet, Christophe | |
| 245 | 0 | 0 |
_a[Olaparib and pancreatic cancer: A challenging Lesson]. _h[electronic resource] |
| 260 |
_bBulletin du cancer _cSep 2019 |
||
| 300 |
_a715-716 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aGenes, BRCA1 |
| 650 | 0 | 4 | _aGenes, BRCA2 |
| 650 | 0 | 4 | _aGerm-Line Mutation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPhthalazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aProgression-Free Survival |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 700 | 1 | _aSamalin, Emmanuelle | |
| 700 | 1 | _aMichel, Pierre | |
| 773 | 0 |
_tBulletin du cancer _gvol. 106 _gno. 9 _gp. 715-716 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bulcan.2019.07.002 _zAvailable from publisher's website |
| 999 |
_c29992362 _d29992362 |
||